Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Neurology | Psychiatry/Psychology | Musculoskeletal

Tardive Dyskinesia Clinical Trials


A listing of Tardive Dyskinesia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Arkansas

Little Rock : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

California

Anaheim : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Carson : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Colton : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Costa Mesa : Updated

NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia

Costa Mesa : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

View More »

Downey : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Fountain Valley : Updated

NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia

Fountain Valley : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Glendale : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

National City : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Oceanside : Updated

NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia

Oceanside : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Paramount : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

San Bernadino : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

San Diego : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Santa Ana : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Florida

Fort Lauderdale : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Hialeah : Updated

NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia

Hialeah : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Lauderhill : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Melbourne : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

View More »

Miami : Updated

NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia

Miami Springs : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

North Miami : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Orange City : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Georgia

Atlanta : NeuroTrials Research, Inc.

Tardive Dyskinesia in Schizophrenic Patients

View More »

Atlanta : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Illinois

Chicago : Updated

NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia

Chicago : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Schaumburg : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Louisiana

New Orleans : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Shreveport : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Maryland

Baltimore : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Glen Burnie : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Michigan

Farmington Hills : Updated

NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia

Missouri

St. Louis : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

New Jersey

Toms River : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Ohio

Beachwood : Updated

NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia

Beachwood : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Middleburg Heights : Updated

NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia

Oklahoma

Oklahoma City : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Pennsylvania

Conshohocken : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Conshohoken : Updated

NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia

Phoenixville : Updated

NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia

South Carolina

Charleston : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Tennessee

Memphis : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Texas

DeSoto : Updated

NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia

DeSoto : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Houston : Updated

NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia

Irving : Updated

NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia

Irving : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Washington

Bothell : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Canada

Toronto : Centre for Addiction and Mental Health

Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia

Victoria : Vancouver Island Health Authority

Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia

Windsor : Windsor Regional Hospital

Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia

India

Chennai : Schizophrenia Research Foundation (SCARF) Mental Health Centre

Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia

Puerto Rico

Caguas : Updated

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)